{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:31:15Z","timestamp":1790803875660,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.contraception.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T13:16:11Z","timestamp":1344863771000},"page":"358-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination"],"prefix":"10.1016","volume":"87","author":[{"given":"Kadriye","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Yazgan","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent Okan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.07.005_bb0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2003.08.018","article-title":"Body composition characteristics and fat distribution patterns in young infertile women","volume":"81","author":"Kirchengast","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.005_bb0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.005_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(99)00203-4","article-title":"Bone mineral density and body composition in lean women with polycystic ovary syndrome","volume":"72","author":"Good","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.07.005_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2005.11.012","article-title":"The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome","volume":"126","author":"Yucel","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.07.005_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.07.005_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk\u2013benefit assessment","volume":"26","author":"Yildiz","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.contraception.2012.07.005_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2010.01.022","article-title":"Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome","volume":"82","author":"Uras","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.005_bb0045","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol\u2013drospirenone, flutamide\u2013metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.07.005_bb0055","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.005_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0070","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0075","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.07.005_bb0080","first-page":"372","article-title":"Influence of weight and distribution of adipose tissue in functional hyperandrogenism","volume":"26","author":"Pasquali","year":"1998","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.contraception.2012.07.005_bb0085","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.07.005_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajpa.10364","article-title":"Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women","volume":"124","author":"Horejsi","year":"2004","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.contraception.2012.07.005_bb0095","doi-asserted-by":"crossref","unstructured":"Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. CD003987. (2006).","DOI":"10.1002\/14651858.CD003987.pub2"},{"key":"10.1016\/j.contraception.2012.07.005_bb0100","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.07.005_bb0105","first-page":"228","article-title":"Impedance: a valid method in assessment of body composition?","volume":"48","author":"Heitmann","year":"1994","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.contraception.2012.07.005_bb0110","first-page":"1029","article-title":"Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis","volume":"7","author":"Bolanowski","year":"2001","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.contraception.2012.07.005_bb0115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0899-9007(00)00402-0","article-title":"Evaluation of a new bioelectrical impedance instrument for the prediction of body cell mass independently of height or weight","volume":"16","author":"Ward","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.contraception.2012.07.005_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000324546","article-title":"Measuring abdominal adipose tissue: comparison of simpler methods with MRI","volume":"4","author":"Browning","year":"2011","journal-title":"Obes Facts"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:59Z","timestamp":1761432299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412006713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0010782412006713"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.005","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}